Back to search

Article

Pathways with an impact on effects of metronomic chemotherapy with a fluoropyrimidine prodrug, S-1

2025-04-21

Abstract excerpt

<h4>Background: </h4> and Purpose Adjuvant chemotherapy with 5-fluorouracil (5-FU) prodrugs is now the standard of care for stage I–III oral squamous cell carcinoma (OSCC); however, it remains to be clarified for which patient neoadjuvant chemotherapy with 5-FU prodrugs may be an option. Experimental Approach In the Ryukyu cohort [neoadjuvant chemotherapy with 5-FU prodrugs (UFT or S-1) + bleomycin, neoadjuvant ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7e206100-a16f-5151-a239-ab9f5a13f919
DOI
10.22541/au.174521795.53239906/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pathways with an impact on effects of metronomic chemotherapy with a fluoropyrimidine prodrug, S-1DOI 10.22541/au.174521795.53239906/v1
Select a neighboring publication to make it the new centre.